IMPACT International GmbH

IMPACT International GmbH was founded in 2018 to facilitate the international sales of IMPACT Platform for Autologous Cell Therapies and to serve distribution partners across the world. IMPACT Platform for Autologous Cell Therapies is the revolutionary new centrifuge for the preparation of many different autologous blood preparations. The Platform is manufactured in Germany and CE marked by Plasmaconcept AG, Cologne.